Abstract

BackgroundRheumatoid arthritis (RA) synovial tissue has been demonstrated to express high levels of fibroblast activation protein (FAP) using anti-FAP-antibody 28H1. In addition, RA patients show elevated levels of IL-22 and...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract A62: Inhibition of tumor growth by novel CART redirected against cells expressing high levels of fibroblast activation protein
Estela Noguera-Ortega ... Jing Sun
Cancer Immunology Research | VOL. 8
Estela Noguera-Ortega, et. al.Estela Noguera-Ortega ... Jing Sun
01 Mar 2020
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3.
Samantha Y.A Terry ... Wim J Oyen
Journal of Nuclear Medicine | VOL. 57
Samantha Y.A Terry, et. al.Samantha Y.A Terry ... Wim J Oyen
03 Dec 2015
Effect of exosome derived from ovarian cancer cell on the differentiation of fibroblast
...
Zhonghua zhong liu za zhi [Chinese journal of oncology] | VOL. 44
, et. al. ...
23 Jul 2022
Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
Tessa Van Der Geest ... Birgitte Walgreen
Journal of Nuclear Medicine | VOL. 58
Tessa Van Der Geest, et. al.Tessa Van Der Geest ... Birgitte Walgreen
04 Aug 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
More than meets the eye
Elise Siegert ... Robert Biesen
Annals of the Rheumatic Diseases | VOL. -
Elise Siegert, et. al.Elise Siegert ... Robert Biesen
31 Aug 2024
Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness
Cecilia Leijding ... Daniel C Andersson
Annals of the Rheumatic Diseases | VOL. -
Cecilia Leijding, et. al.Cecilia Leijding ... Daniel C Andersson
28 Aug 2024
Correspondence on ‘Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis’ by Kim et al
Robert B M Landewé ... Maarten Boers
Annals of the Rheumatic Diseases | VOL. -
Robert B M Landewé, et. al.Robert B M Landewé ... Maarten Boers
28 Aug 2024
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma Register
Eirik Ikdahl ... Anne M Kerola
Annals of the Rheumatic Diseases | VOL. 83
Eirik Ikdahl, et. al.Eirik Ikdahl ... Anne M Kerola
27 Aug 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.